SCHEMBL6803133

SCHEMBL6803133

CC(C)(C)OC(=O)C(N)C1(C(=O)O)CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL335136 0.91 NOS1 (0.31)
SCHEMBL9366367 0.79
SCHEMBL28949298 0.79 NOS1 (0.31)
SCHEMBL5644797 0.78
SCHEMBL1076766 0.78 USP2 (0.39)
SCHEMBL4699779 0.77 PRKCA (0.30)
SCHEMBL5641549 0.76
SCHEMBL4700107 0.75
SCHEMBL27554171 0.74
SCHEMBL2146900 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107567438-B Riluzole prodrugs and uses thereof 拜尔哈文制药股份有限公司 2021-06-29 CN disclosed
US-20040063643-A1 Bombesin antagonists PFIZER INC. 2004-04-01 US disclosed
US-6211241-B1 ANTIDEPRESSANTS, SLEEP AND EATING DISORDERS AND ANTIEPILEPTIC AGENTS SYNAPTIC PHARMACEUTICAL CORPORATION 2001-04-03 US disclosed
EP-0317959-A2 Anti-ulcer composition Okamoto, Shosuke (JP) 1989-05-31 EP disclosed